Mefenorex
Source: Wikipedia, the free encyclopedia.
Pharmaceutical drug
Clinical data | |
---|---|
Trade names | Rondimen, Pondinil, Anexate |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
JSmol) | |
| |
| |
(verify) |
Mefenorex (Rondimen, Pondinil, Anexate) is a
appetite suppressant. It is an amphetamine derivative which was developed in the 1970s and used for the treatment of obesity.[2][3] Mefenorex produces amphetamine as a metabolite,[4] and has been withdrawn in many countries despite having only mild stimulant effects and relatively little abuse potential.[5]
References
- ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
- PMID 5455004.
- PMID 7374423.
- S2CID 7170057.
- PMID 3743406.
antagonists
receptor agonists
- Beloranib§
- Bimagrumab§
- Desiccated thyroid‡
- Metformin
- Metreleptin
- Naltrexone
- Setmelanotide
- Topiramate
- ZGN-1061
- Zonisamide
- Water
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
Phenethylamines |
|
---|---|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|